PFPamela L. Ferguson

Pamela L. Ferguson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Pamela L. Ferguson has a total of 74 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Oral microbial profiles in young adults with cannabis use disorder

    by Brittney D. Browning, Rachel L. Tomko, Anna E. Kirkland, Rachel Visontay, Pamela L. Ferguson, Alexander V. Alekseyenko, Melinda A. Engevik, Louise Mewton, Lindsay M. Squeglia


  • Effect of N‐acetylcysteine on neural alcohol cue reactivity and craving in adolescents who drink heavily: A preliminary randomized clinical trial

    by ReJoyce Green, Anna E. Kirkland, Brittney D. Browning, Pamela L. Ferguson, Kevin M. Gray, Lindsay M. Squeglia

    Background: Alcohol craving is related to problematic alcohol use; therefore, pharmacotherapies that modulate alcohol craving are of interest. N‐acetylcysteine, an over‐the‐counter antioxidant, is a candidate pharmacotherapy for adolescent alcohol use with the potential to impact craving. Cue‐reactivity paradigms using functional magnetic resonance imaging (fMRI) can identify neural regions implicated in craving and serve as a screening tool for novel pharmacotherapy options.Methods: This preliminary study examined the effect of N‐acetylcysteine on neural reactivity to alcohol cues and subjective craving among 31 non‐treatment‐seeking adolescents (17.6–19.9 years old, 55% female) who use alcohol heavily. In a randomized cross‐over design, participants completed three fMRI sessions: baseline and after a 10‐day course of N‐acetylcysteine (1200 mg twice daily) and matched placebo. The primary outcome was neural response to alcohol versus non‐alcohol beverage cues after N‐acetylcysteine versus placebo, with a secondary outcome of self‐reported subjective craving.Results: In the full sample (n = 31), there was no effect of N‐acetylcysteine versus placebo on neural alcohol reactivity (ps ≥ 0.49; s = 0.00–0.07) or self‐reported acute alcohol craving (p = 0.18, = 0.06). However, N‐acetylcysteine did reduce self‐reported generalized alcohol craving (p = 0.03, = 0.15). In a subsample of youth who met criteria for past‐year alcohol use disorder (n = 19), results remained unchanged.Conclusions: N‐acetylcysteine may not alter neural reactivity to alcohol cues or acute craving; however, it may reduce general subjective alcohol craving among adolescents who consume alcohol heavily.


  • Open Access

    Phthalate and phthalate replacement concentrations in relationship to adiposity in a multi-racial cohort of children

    by Kelly J. Hunt, Kelly J. Hunt, Pamela L. Ferguson, Pamela L. Ferguson, Michael S. Bloom, Michael S. Bloom, Brian Neelon, Brian Neelon, John Pearce, John Pearce, et al.

    Background/Objective: Phthalates and phthalate replacements are used in multiple everyday products, making many of them bioavailable to children. Experimental studies suggest that phthalates and their replacements may be obesogenic, however, epidemiologic studies remain inconsistent. Therefore, our objective was to examine the association between phthalates, phthalate replacements and childhood adiposity/obesity markers in children. Subjects/Methods: A cross-sectional study was conducted in 630 racial/ethnically diverse children ages 4–8 years. Urinary oxidative metabolites of DINCH and DEHTP, three low molecular weight (LMW) phthalates, and eleven high molecular weight (HMW) phthalates were measured. Weight, height, waist circumference and % body fat were measured. Composite molar sum groups (nmol/ml) were natural log-transformed. Linear regression models adjusted for urine specific gravity, sex, age, race-ethnicity, birthweight, breastfeeding, reported activity level, mother’s education and pre-pregnancy BMI. Results: All children had LMW and HMW phthalate metabolites and 88% had DINCH levels above the limit of detection. One unit higher in the log of DINCH was associated with 0.106 units lower BMI z-score [β = −0.106 (95% CI: −0.181, −0.031)], 0.119 units lower waist circumference z-score [β = −0.119 (95% CI: −0.189, −0.050)], and 0.012 units lower percent body fat [β = −0.012 (95% CI: −0.019, −0.005)]. LMW and HMW group values were not associated with adiposity/obesity. Conclusions: We report an inverse association between child urinary DINCH levels, a non-phthalate plasticizer that has replaced DEHP in several applications, and BMI z-score, waist circumference z-score and % body fat in children. Few prior studies of phthalates and their replacements in children have been conducted in diverse populations. Moreover, DINCH has not received a great deal of attention or regulation, but it is a common exposure. In summary, understanding the ubiquitous nature of these chemical exposures and ultimately their sources will contribute to our understanding of their relationship with obesity.


  • Multi-modal neuroimaging reveals differences in alcohol-cue reactivity but not neurometabolite concentrations in adolescents who drink alcohol

    by Anna E. Kirkland, ReJoyce Green, Brittney D. Browning, Stephanie Aghamoosa, Dieter J. Meyerhoff, Pamela L. Ferguson, Rachel L. Tomko, Kevin M. Gray, Lindsay M. Squeglia


  • Pairwise comparisons of three medication adherence outcomes in adolescents who use alcohol

    by Anna E. Kirkland, Rachel L. Tomko, ReJoyce Green, Brittney D. Browning, Pamela L. Ferguson, Helen Liu, Robert Miranda, Kevin M. Gray, Lindsay M. Squeglia

    Background: Accurate assessment of medication adherence is important for understanding pharmacotherapy outcomes across all phases of adolescent substance use disorder (SUD) clinical trials. The objective of this study was to describe and assess the pairwise concordance between three commonly used non‐biological medication adherence assessment methods in adolescents who use alcohol to inform the selection of medication adherence measures for use in future youth SUD trials.Methods: Participants (N = 32, 17–19‐years‐old) took N‐acetylcysteine and placebo, in a randomized cross‐over design, for 10 days each. Medication adherence was assessed (20 days total) via pill count, medication videos submitted twice daily, and the Medication Event Monitoring System (MEMS®). Lin's Concordance Correlation Coefficient (CCC) assessed concordance and Bland–Altman plots are reported. Linear mixed‐effects models with main effects of medication, treatment block (first medication, second medication), and sequence were also run.Results: Medication videos yielded the lowest (64%) and pill count yielded the highest (89%) adherence estimates. CCC values indicated poor correspondence, except between pill count and MEMS. The Bland–Altman plots showed good pairwise agreement between all methods. Linear mixed‐effects models indicated a difference between the first and second cross‐over medication, with adherence estimates being lower for the second medication, regardless of whether it was N‐acetylcysteine or placebo.Conclusions: The study yielded important and practical information. First, incorporating more than one method of adherence assessment may capture estimated floor and ceiling adherence in the absence of a biological marker. This is particularly relevant for remote or hybrid studies where bio‐marker collection is challenging. Selection of the assessment methods will depend on study goals. Second, the continuation of medication adherence research can benefit each phase of clinical trials and inform rigorous pharmacotherapy evaluation.


  • Open Access

    N-acetylcysteine does not alter neurometabolite levels in non-treatment seeking adolescents who use alcohol heavily: A preliminary randomized clinical trial

    by Anna E. Kirkland, Brittney D. Browning, ReJoyce Green, Helen Liu, Anna M. Maralit, Pamela L. Ferguson, Dieter J. Meyerhoff, James J. Prisciandaro, Robert Miranda, Kathleen T. Brady, et al.

    Current treatments for adolescent alcohol use disorder (AUD) are mainly psychosocial and limited in their efficacy. As such, pharmacotherapies are being investigated as potential adjunctive treatments to bolster treatment outcomes. N-acetylcysteine is a promising candidate pharmacotherapy for adolescent AUD because of its tolerability and demonstrated ability to modulate glutamatergic, GABAergic, and glutathione systems. The primary objective of this double-blind, placebo-controlled, within-subjects crossover preliminary investigation was to measure potential changes within glutamate + glutamine (Glx), GABA, and glutathione levels in the dorsal anterior cingulate cortex (dACC) using proton magnetic resonance spectroscopy during 10-days of N-acetylcysteine (1200 mg twice daily) compared to 10-days of placebo in non-treatment seeking adolescents who use alcohol heavily (N = 31; 55% female). Medication adherence was confirmed via video. Effects on alcohol use were measured using Timeline Follow-Back as an exploratory aim. Linear mixed effects models controlling for baseline metabolite levels, brain tissue composition, alcohol use, cannabis use, and medication adherence found no significant differences in Glx, GABA, or glutathione levels in the dACC after N-acetylcysteine compared to placebo. There were also no measurable effects on alcohol use; however, this finding was underpowered. Findings were consistent in the subsample of participants who met criteria for AUD (n = 19). The preliminary null findings in brain metabolite levels may be due to the young age of participants, relatively low severity of alcohol use, and non-treatment seeking status of the population investigated. Future studies can use these findings to conduct larger, well-powered studies within adolescents with AUD.


  • Breastfeeding Associations with Childhood Obesity and Body Composition: Findings from a Racially Diverse Maternal–Child Cohort

    by Janet S. Hildebrand, Pamela L. Ferguson, Anthony C. Sciscione, William A. Grobman, Roger B. Newman, Alan T. Tita, Ronald J. Wapner, Michael P. Nageotte, Kristy Palomares, Daniel W. Skupski, et al.

    Background: Studies suggest breastfeeding lowers obesity risk in childhood, but generalizability of existing evidence is limited. We examined associations of breastfeeding with childhood overweight, obesity, and percentage body fat, in a racially diverse maternal–child cohort. Methods: This cross-sectional study included 823 children, ages 4–8 years, enrolled in the Environmental Exposures and Child Health Outcomes (ECHO) cohort, a subset of the National Institute of Child Health and Human Development Fetal Growth Studies cohort. Logistic regression was used to estimate odds ratios and 95% confidence intervals (CIs) for overweight [BMI (kg/m2) 85th to Results: Fifty-two percent of children were male, 32% non-Hispanic Black, 29% Hispanic, 27% non-Hispanic White, and 13% Asian; 16% were overweight and 13% obese. Six months of exclusive breastfeeding, compared with no breastfeeding, was associated with 60% lower odds of obesity (95% CI 0.18–0.91) adjusting for age, gender, race, socioeconomic status, maternal BMI, and child's activity. Percentage body fat was inversely associated with breastfeeding duration. For none, Conclusions: Exclusive breastfeeding for the first 6 months of life is inversely and significantly associated with obesity and percentage body fat at ages 4–8 years. These findings support current breastfeeding guidelines.


  • Associations of Maternal Prenatal Stress and Depressive Symptoms With Childhood Neurobehavioral Outcomes in the ECHO Cohort of the NICHD Fetal Growth Studies: Fetal Growth Velocity as a Potential Mediator

    by Vanessa Babineau, Yaneve N. Fonge, Emily S. Miller, William A. Grobman, Pamela L. Ferguson, Kelly J. Hunt, John E. Vena, Roger B. Newman, Constance Guille, Alan T.N. Tita, et al.


  • The association between maternal pre‐pregnancy BMI, gestational weight gain and child adiposity: A racial‐ethnically diverse cohort of children

    by Kelly J. Hunt, Pamela L. Ferguson, Brian Neelon, Sarah Commodore, Michael S. Bloom, Anthony C. Sciscione, William A. Grobman, Michelle A. Kominiarek, Roger B. Newman, Alan T. Tita, et al.

    Summary: Background: The prevalence of obesity in US children has more than tripled in the past 40 years; hence, it is critical to identify potentially modifiable factors that may mitigate the risk.Objectives: To examine the association between maternal pre‐pregnancy body mass index (BMI), gestational weight gain (GWG) and child adiposity as measured by BMI, waist circumference and percent body fat in a racial‐ethnically diverse cohort.Methods: In a prospective cohort study of healthy women without chronic disease, we examined the association between pre‐pregnancy BMI, GWG and child adiposity. Children ages 4–8 years (n = 816) in the Environmental Influences on Child Health Outcomes‐NICHD Fetal Growth Studies were assessed. Trained study staff ascertained maternal pre‐pregnancy BMI, GWG and child adiposity.Results: The odds of child obesity (≥95th BMI percentile) increased independently for each unit increase in maternal pre‐pregnancy BMI [OR = 1.12 (95% CI: 1.08, 1.17)] and for each 5‐kg increase in GWG [OR = 1.25 (95% CI: 1.07, 1.47)]. The odds of child waist circumference (≥85th percentile) also increased independently for pre‐pregnancy BMI [OR = 1.09 (95% CI: 1.05, 1.12)] and GWG [OR = 1.18 (95% CI: 1.04, 1.34)].Conclusions: Maternal pre‐pregnancy BMI and GWG were each independently and positively associated with child obesity and high child waist circumference.